Claudio Brescia
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Pharmacotherapeutic strategies for the treatment of severe juvenile acne.
Journal: Expert opinion on pharmacotherapy
Published: August 05, 2026
Cumulative Life Course Impairment in Atopic Dermatitis: A Comprehensive Review.
Journal: Medical sciences (Basel, Switzerland)
Published: July 01, 2026
Minimal disease activity in atopic dermatitis: a 24-week real-life comparison of JAK inhibitors.
Journal: Italian journal of dermatology and venereology
Published: June 29, 2026
Hidradenitis Suppurativa and IL-17 Inhibitors: A Focus on Trials and Real-Life Data.
Journal: Medicina (Kaunas, Lithuania)
Published: March 30, 2026
West Nile virus: a diagnostic challenge for dermatologists.
Journal: Italian journal of dermatology and venereology
Published: March 27, 2026
Effectiveness of Baricitinib in Treating Atopic Dermatitis in Difficult-to-treat Areas: A Retrospective Real-world Study.
Journal: Acta dermato-venereologica
Published: January 29, 2026
A 52-Week Retrospective Italian Study of Flare Characteristics in Adult Atopic Dermatitis Patients Receiving JAK Inhibitors.
Journal: International journal of dermatology
Published: December 18, 2025
Head and Neck Dermatitis in Atopic Dermatitis: A Narrative Review of Pathogenesis, Clinical Challenges, and Therapeutic Strategies.
Journal: Antibodies (Basel, Switzerland)
Published: October 21, 2025
Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use.
Journal: Expert opinion on biological therapy
Published: June 16, 2025
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis).
Journal: Archives of dermatological research
Published: February 27, 2025
Allergic Contact Dermatitis From a Polyester Trouser Mimicking Atopic Dermatitis.
Journal: Contact dermatitis
Published: January 08, 2025
Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life Study.
Journal: Dermatology and therapy
Published: December 23, 2024
Last Updated: 09/26/2026